Obesity and Inflammation - Targets for OA Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|11|5|586-598

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.5, 2010-05, pp. : 586-598

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Celecoxib: a model therapy for RA and OA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Role of the Autonomic Nervous System and Neuropeptides in the Development of Obesity in Humans: Targets for Therapy?

By  

Current Pharmaceutical Design, Vol. 14, Iss. 18, 2008-06 ,pp. : 1815-1820

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of obesity: targets and perspectives

By Chiesi M.   Huppertz C.   Hofbauer K.G.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 5, 2001-05 ,pp. : 247-254

Elsevier

Access to resources Recommend Favorite

Kinase targets in inflammation

By Scherle P.A.   Trzaskos J.M.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 1, 1999-03 ,pp. : 1-25

Informa Healthcare

Access to resources Recommend Favorite

Tachykinins as Therapeutic Targets in Inflammation

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 2, Iss. 1, 2003-03 ,pp. : 19-27

Bentham Science Publishers

Access to resources Recommend Favorite